| Segment Reporting [Text Block] |
Note 9 – Segment Information
We manage our business activities on a consolidated basis and operate as a single operating segment dedicated to developing and marketing products for chronic wound care that harness the regenerative capacity of the human body to trigger natural healing. We derive our revenue from sales of the Aurix and Private Label branded product lines and distribution fee revenue from Smith+Nephew. The accounting policies of the segment are the same as those described in Note 2 – Liquidity and Summary of Significant Accounting Policies.
Our CODM is Nuo’s Chief Executive and Financial Officer, David E. Jorden. The CODM uses net loss, as reported in our consolidated statements of operations, in evaluating the performance of the segment and determining how to allocate our resources as a whole. The CODM does not review assets in evaluating the results of the segment, and therefore, such information is not presented.
The following table presents the operating results of the segment:
| |
|
Three Months
Ended
September 30,
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Total revenues
|
|
$ |
1,866,125 |
|
|
$ |
1,032,096 |
|
|
$ |
4,937,226 |
|
|
$ |
2,216,679 |
|
|
Less significant segment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aurix cost of sales (excluding provision for inventory obsolescence and applicable depreciation expense)
|
|
|
316,731 |
|
|
|
137,911 |
|
|
|
891,239 |
|
|
|
379,410 |
|
|
Private label cost of sales
|
|
|
322,155 |
|
|
|
250,267 |
|
|
|
760,430 |
|
|
|
250,267 |
|
|
Total compensation and benefit costs (including third party commission expense)
|
|
|
874,325 |
|
|
|
674,499 |
|
|
|
2,528,468 |
|
|
|
1,883,308 |
|
|
Provisions for credit losses and inventory obsolescence
|
|
|
73,960 |
|
|
|
28,876 |
|
|
|
73,960 |
|
|
|
50,520 |
|
|
All other operating expenses (excluding depreciation and credit loss provision) (a)
|
|
|
503,655
|
|
|
|
419,549 |
|
|
|
1,369,033 |
|
|
|
1,413,497 |
|
|
Other segment items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation, amortization of right of use assets, and stock-based compensation
|
|
|
149,731 |
|
|
|
61,136 |
|
|
|
301,546 |
|
|
|
176,988 |
|
|
Interest expense (income), net
|
|
|
51,099 |
|
|
|
(409 |
) |
|
|
340,447 |
|
|
|
33 |
|
|
Other expense (income), net
|
|
|
(603 |
) |
|
|
(1,814 |
) |
|
|
(6,902 |
) |
|
|
(3,608 |
) |
|
Consolidated net loss
|
|
$ |
(424,928 |
) |
|
$ |
(537,919 |
) |
|
$ |
(1,320,995 |
) |
|
$ |
(1,933,736 |
) |
| |
(a)
|
All other operating expenses included in consolidated net loss includes professional fees, lease expenses, insurance costs, travel and entertainment expenses, and all other selling, general and administrative expenses.
|
|